1 / 1

ISAR-TEST-4

ISAR-TEST-4. Cardiac death, MI, or TLR at 12 months: 13.8% of the biodegradable polymer group vs. 14.4% of the permanent polymer group Cardiac death: 2.8% vs. 3.2% (p = 0.5) ARC definite/probable stent thrombosis: 1.0% vs. 1.5% (p = 0.29).

francesca-hoffman
Download Presentation

ISAR-TEST-4

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ISAR-TEST-4 Cardiac death, MI, or TLR at 12 months: 13.8% of the biodegradable polymer group vs. 14.4% of the permanent polymer group Cardiac death: 2.8% vs. 3.2% (p = 0.5) ARC definite/probable stent thrombosis: 1.0% vs. 1.5% (p = 0.29) Trial design: Patients with stable coronary disease or ACS were randomized to the biodegradable polymer DES (rapamycin-eluting; n = 1,299) vs. permanent polymer DES (sirolimus-eluting, n = 652 or everolimus-eluting, n = 652). Mean follow-up was 1 year. Results (p for non-inferiority = 0.005) (p = NS) % Conclusions • Among patients with either stable coronary disease or ACS undergoing stent implantation, a biodegradable polymer DES was non-inferior to a permanent polymer-based DES • Biodegradable polymer DES associated with similar frequency of the composite endpoint of cardiac death, MI, or TLR at 12 months Cardiac death, MI, or TLR at 12 months Cardiac death Biodegradable polymer group Permanent polymer group Byrne RA, et al. Eur Heart J 2009;Aug 30:[Epub]

More Related